Encompass Health (NYSE:EHC) versus Ceres Ventures (OTCMKTS:CEVE) Head-To-Head Contrast

Encompass Health (NYSE:EHC) and Ceres Ventures (OTCMKTS:CEVE) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Volatility and Risk

Encompass Health has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Ceres Ventures has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500.

Valuation & Earnings

This table compares Encompass Health and Ceres Ventures”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Encompass Health	$5.37 billion	2.37	$455.70 million	$5.11	24.74
Ceres Ventures	N/A	N/A	N/A	N/A	N/A

Encompass Health has higher revenue and earnings than Ceres Ventures.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Encompass Health and Ceres Ventures, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Encompass Health	0	0	8	2	3.20
Ceres Ventures	0	0	0	0	0.00

Encompass Health currently has a consensus price target of $139.86, suggesting a potential upside of 10.65%. Given Encompass Health’s stronger consensus rating and higher possible upside, analysts clearly believe Encompass Health is more favorable than Ceres Ventures.

Profitability

This table compares Encompass Health and Ceres Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Encompass Health	9.22%	17.83%	7.68%
Ceres Ventures	N/A	N/A	N/A

Institutional & Insider Ownership

97.3% of Encompass Health shares are held by institutional investors. 2.1% of Encompass Health shares are held by insiders. Comparatively, 0.1% of Ceres Ventures shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Encompass Health beats Ceres Ventures on 10 of the 11 factors compared between the two stocks.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.